• 21 Oct

    ProMIS Neurosciences Files Special Meeting Proxy Material

    For any questions, please contact ProMIS’ proxy solicitation agent, Laurel Hill Advisory Group at 1-877-452-7184 (+1-416-304-0211 outside North America) or email assistance@laurelhill.com. TORONTO and CAMBRIDGE, Mass., Oct. 21, 2021 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (TSX: PMN) (OTCQB: ARFXF) (the “Company”), a biotechnology company focused on the discovery and development of… Read More..

  • 20 Oct

    American Shared Hospital Services Expands Addressable Market to Federal Facilities

    Includes All Government Funded Facilities in the U.S., including VA & DoD hospitals SAN FRANCISCO, CA, Oct. 20, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today… Read More..

  • 20 Oct

    Lexaria THC Test Results Come in as MORE Act Gains Momentum in Congress

    New York, New York--(Newsfile Corp. - October 20, 2021) - PCG Digital -- Lexaria Bioscience Corp, developers of the revolutionary DehydraTECH™ drug delivery technology, is in the news again this week. On October 13th, the British Columbia-based pharmaceutical company released study results on THC-A21-1, a THC oral format. The study… Read More..

MENU